HUP9901344A2 - Radicicol származékok és ezeket tartalmazó gyógyszerkészítmények - Google Patents

Radicicol származékok és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9901344A2
HUP9901344A2 HU9901344A HUP9901344A HUP9901344A2 HU P9901344 A2 HUP9901344 A2 HU P9901344A2 HU 9901344 A HU9901344 A HU 9901344A HU P9901344 A HUP9901344 A HU P9901344A HU P9901344 A2 HUP9901344 A2 HU P9901344A2
Authority
HU
Hungary
Prior art keywords
group
general formula
hydrogen atom
alkenoyl
alkanoyl
Prior art date
Application number
HU9901344A
Other languages
English (en)
Inventor
Tsutomu Agatsuma
Kazuhito Akasaka
Shiro Akinaga
Katsushige Gomi
Tamio Mizukami
Yutaka Saitoh
Isami Takahashi
Yoshinori Yamashita
Original Assignee
Kyowa Hakko Kogyo Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co., Ltd. filed Critical Kyowa Hakko Kogyo Co., Ltd.
Publication of HUP9901344A2 publication Critical patent/HUP9901344A2/hu
Publication of HUP9901344A3 publication Critical patent/HUP9901344A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

(I) általános képletű radicicolszármazékok - ahol R1 és R2 jelentéseazonosan vagy eltérően hidrogénatom, alkanoil-, alkenoil- vagy terc-butil-dimetil-szilil-csoport; (1) ha X jelentése halogénatom, Y jelentése oxigénatom vagy R4-O-N általános képletű csoport, ahol R4jelentése hidrogénatom vagy adott esetben hidroxil-, alkoxi-,alkanoil-oxi-, azido-, amino-, mono- vagy dialkil-amino-, alkanoil-amino-, alkoxi-karbonil-amino-, alkenil-oxi-karbonil-amino-,karboxil-, alkoxi-karbonil-, alkil-karbamoil- vagy ciklusosimidocsoporttal szubsztituált alkilcsoport; és R3 jelentése hidrogénatom, alkanoil-, alkenoil- vagy -SO-Z- általánosképletű csoport, ahol Z jelentése (A) általános képletű csoport, aholXA, R1A és R2A jelentése az X, R1 és R2 csoportoknál megadott; és YA jelentése oxigénatom vagy R4A-O-N általános képletű csoport, aholR4A jelentése az R4 csoportnál megadott; és (2) ha X és R3 jelentése együtt vegyértékkötés; Y jelentése R4B-O-N általános képletű csoport, ahol R4B jelentése azR4 jelentésénél megadott - és gyógyászatilag alkalmazható sóik. Atalálmány szerinti vegyületek antitumor-, antibakteriális ésimmunszuppresszív hatású gyógyszerkészítményekként alkalmazhatók. Ó
HU9901344A 1995-04-26 1996-04-26 Radicicol derivatives and pharmaceutical compositions thereof HUP9901344A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10262695 1995-04-26
PCT/JP1996/001158 WO1996033989A1 (fr) 1995-04-26 1996-04-26 Derives de radicicol

Publications (2)

Publication Number Publication Date
HUP9901344A2 true HUP9901344A2 (hu) 2001-04-28
HUP9901344A3 HUP9901344A3 (en) 2001-05-28

Family

ID=14332458

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901344A HUP9901344A3 (en) 1995-04-26 1996-04-26 Radicicol derivatives and pharmaceutical compositions thereof

Country Status (13)

Country Link
US (1) US5977165A (hu)
EP (1) EP0823429B1 (hu)
JP (1) JP3938936B2 (hu)
KR (1) KR19990008051A (hu)
AT (1) ATE194610T1 (hu)
AU (1) AU700840B2 (hu)
CA (1) CA2218981C (hu)
DE (1) DE69609325T2 (hu)
ES (1) ES2149468T3 (hu)
HU (1) HUP9901344A3 (hu)
NO (1) NO974890L (hu)
NZ (1) NZ311790A (hu)
WO (1) WO1996033989A1 (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2216130T3 (es) 1996-10-25 2004-10-16 Kyowa Hakko Kogyo Co., Ltd. Derivados de radicicol.
AU740668B2 (en) * 1997-07-25 2001-11-08 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Macrocyclic lactones, compositions, and methods of use
AU3534499A (en) * 1998-04-24 1999-11-16 Kyowa Hakko Kogyo Co. Ltd. Radicicol derivatives
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
EP1140069A1 (en) 1998-12-24 2001-10-10 Novation Pharmaceuticals Inc. COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
MXPA03000708A (es) 2000-07-26 2003-06-04 Smithkline Beecham Plc Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
WO2002016369A2 (en) * 2000-08-25 2002-02-28 Sloan-Kettering Institute For Cancer Research Novel macrocycles and uses thereof
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AU2002310065B2 (en) * 2001-05-23 2007-07-05 Sloan Kettering Institute For Cancer Research Method of treatment for cancers associated with elevated HER 2 levels
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US20040192638A1 (en) * 2001-07-02 2004-09-30 Oaks John A. Method and composition for prolonging the residence time of drugs in the gut
EP1470131A2 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
JP4575294B2 (ja) 2003-06-27 2010-11-04 協和発酵キリン株式会社 Ｈｓｐ９０ファミリー蛋白質阻害剤
WO2005018674A1 (ja) * 2003-08-22 2005-03-03 Kyowa Hakko Kogyo Co., Ltd. イムノグロブリン遺伝子の転座を伴う疾患の治療薬
WO2005061481A1 (en) * 2003-12-19 2005-07-07 Sloan-Kettering Institute For Cancer Research Novel ma crocycles and uses thereof
ES2651019T3 (es) 2006-08-11 2018-01-23 Universite De Strasbourg Compuestos macrocíclicos útiles como inhibidores de cinasas y de HSP90
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
RU2534527C2 (ru) * 2008-01-15 2014-11-27 Юниверсите Де Страсбур Синтез лактонов резорциловой кислоты, используемых в качестве терапевтических агентов
CN102015673B (zh) * 2008-02-21 2014-10-29 昂科协同公司 用作治疗剂的大环前药化合物
WO2016196256A2 (en) 2015-06-04 2016-12-08 University Of North Carolina At Greensboro Non-aromatic difluoro analogues of resorcylic acid lactones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228079A (en) * 1978-10-30 1980-10-14 W. R. Grace & Co. Dialkoxy monorden derivatives
IE911915A1 (en) * 1990-06-06 1991-12-18 Sankyo Co Radicicol derivatives, their preparation and their¹anti-tumor activity
GB9225396D0 (en) * 1992-12-04 1993-01-27 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE69609325D1 (de) 2000-08-17
EP0823429A1 (en) 1998-02-11
CA2218981C (en) 2007-01-16
US5977165A (en) 1999-11-02
EP0823429B1 (en) 2000-07-12
ATE194610T1 (de) 2000-07-15
HUP9901344A3 (en) 2001-05-28
EP0823429A4 (en) 1998-07-08
AU700840B2 (en) 1999-01-14
KR19990008051A (ko) 1999-01-25
JP3938936B2 (ja) 2007-06-27
WO1996033989A1 (fr) 1996-10-31
DE69609325T2 (de) 2000-11-23
ES2149468T3 (es) 2000-11-01
NZ311790A (en) 1999-04-29
AU6292796A (en) 1996-11-18
NO974890D0 (no) 1997-10-23
CA2218981A1 (en) 1996-10-31
NO974890L (no) 1997-12-29

Similar Documents

Publication Publication Date Title
HUP9901344A2 (hu) Radicicol származékok és ezeket tartalmazó gyógyszerkészítmények
IL110091A (en) POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2100258A1 (en) Acridine Derivatives
TW351668B (en) Oxymethoxy-3-aryl-pyrone derivatives, their preparation, their use for controlling pest and pesticides containing the same
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
AU2897189A (en) Pt (iv) complexes
AU3802589A (en) Quinoline derivatives, their production and use
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
ES8305325A1 (es) "procedimiento para preparar derivados de 2-oxoazetidina".
ES8706713A1 (es) Un procedimiento para preparar derivados de 4'-desmetil-4-epipodofilotoxina
AU4254585A (en) Cephalosporin derivatives
HUP9702393A2 (hu) bisz(2-Halogén-etil)-amino-fenil szubsztituált distamycinszármazékok, tumorellenes és vírusellenes hatóanyagok
KR910005859A (ko) 항종양제
MX170732B (es) Composicion de derivados de succinimida y su uso
CA2082820A1 (en) Derivatives of 6-aminooctahydroindolizinetriol
AU8383691A (en) Amelinic compounds and use thereof in self-extinguishing polymeric compositions
WO1995016695A3 (en) 3'-aziridino-anthracycline derivatives
MX9706014A (es) Derivados de xanteno y acridina y su empleo.
HUP0004602A2 (hu) Pirazin -és piridin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
FI913699A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 4'-epi-4'-aminoantrasykliinien valmistamiseksi sekä menetelmässä käytettävät välituotteet
ES8203917A1 (es) Un procedimiento para la preparacion de un derivado de nu- cleosido de adenina
AU2307595A (en) A process for the preparation of 5,6-dihydroxy-2-amino- 1,2,3,4-tetrahydronaphthalene derivatives
HUP9702411A2 (hu) Fenoxi-alkil-amin-származékok és a vegyületeket tartalmazó antiaritmiás hatású gyógyszerkészítmények
ES2000678A6 (es) Procedimiento para la obtencion de embonatos de los acidos quinolon-carboxilicos y sus derivados
AU8891891A (en) Novel antitumoral and antiviral compound